CVA Family Office’s Lifestance Health LFST Stock Holding History

CVA Family Office’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.75K	Buy	350 +236	+207%	+$1.82K	﹤0.01%	1360
2026 Q1	$726	Buy	+114	New	+$793	﹤0.01%	1700

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

CVA Family Office's LFST Position: Q2 2026 in Review

CVA Family Office increased its Lifestance Health (LFST) stake by 207% in Q2 2026, buying an estimated $1.82K and bringing the position to 350 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1360.

CVA Family Office first reported a position in LFST in Q1 2026 and has held it in 2 quarters since. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

CVA Family Office held 350 shares of Lifestance Health worth $3.75K as of Q2 2026.
CVA Family Office bought 236 Lifestance Health shares in Q2 2026, an estimated $1.82K.
Lifestance Health made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1360 holding.
CVA Family Office first reported a position in Lifestance Health in Q1 2026 and has held it in 2 quarters since.
288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.